Stryker
Stock Forecast, Prediction & Price Target
Stryker (SYK) stock Price Target by analysts
Stryker (SYK) stock Price Target by analysts
Average Price Target
$403.63
Potential upside: 3.50%
Stryker price prediction
What is Stryker stock analysts` prediction?
Stryker stock forecast: Based on 6 Wall Street analysts` predicted price targets for Stryker in the last 3 months, the avarage price target is $403.63, with a high forecast of $NaN. The average price target represents a 3.50% change from the last price of $389.94.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Stryker stock Price Target by analysts
Full breakdown of analysts given Stryker price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Richard Newitter Truist Financial | 20% 1/5 | 9 months ago | $409 4.88% upside | $359.17 | TheFly | Previous targets (4) |
Patrick Wood Morgan Stanley | 0% 0/1 | 10 months ago | $445 14.12% upside | $390.9 | StreetInsider | Previous targets (0) |
Joanne Wuensch Citigroup | 0% 0/1 | 11 months ago | $411 5.40% upside | $363.43 | TheFly | Previous targets (0) |
Kyle Rose Canaccord Genuity | 50% 1/2 | 11 months ago | $400 2.57% upside | $359.01 | StreetInsider | Previous targets (1) |
Ryan Zimmerman BTIG | 28.57% 2/7 | 11 months ago | $394 1.04% upside | $359.01 | StreetInsider | Previous targets (6) |
Matt O'Brien Piper Sandler | 20% 1/5 | 11 months ago | $420 7.70% upside | $367.95 | StreetInsider | Previous targets (4) |
Richard Newitter Truist Financial | 20% 1/5 | 11 months ago | $380 -2.54% downside | $365.42 | StreetInsider | Previous targets (4) |
Richard Newitter Truist Financial | 20% 1/5 | 11 months ago | $370 -5.11% downside | $356.45 | TheFly | Previous targets (4) |
Matt O'Brien Piper Sandler | 20% 1/5 | about 1 year ago | $380 -2.54% downside | $365.22 | StreetInsider | Previous targets (4) |
Ryan Zimmerman BTIG | 28.57% 2/7 | about 1 year ago | $374 -4.08% downside | $358.51 | TheFly | Previous targets (6) |
Richard Newitter Truist Financial | 20% 1/5 | about 1 year ago | $345 -11.52% downside | $327 | TheFly | Previous targets (4) |
Ryan Zimmerman BTIG | 28.57% 2/7 | about 1 year ago | $360 -7.67% downside | $330.22 | TheFly | Previous targets (6) |
David Roman Goldman Sachs | 0% 0/1 | over 1 year ago | $372 -4.60% downside | $341.14 | StreetInsider | Previous targets (0) |
David Toung Argus Research | 33.33% 1/3 | over 1 year ago | $380 -2.54% downside | $330.51 | TheFly | Previous targets (2) |
Mike Matson Needham | 0% 0/1 | over 1 year ago | $392 0.52% upside | $330.51 | TheFly | Previous targets (0) |
Ryan Zimmerman BTIG | 28.57% 2/7 | over 1 year ago | $366 -6.13% downside | $342.05 | TheFly | Previous targets (6) |
Matt O'Brien Piper Sandler | 20% 1/5 | over 2 years ago | $280 -28.19% downside | $253.81 | TheFly | Previous targets (4) |
Unknown Morgan Stanley | N/A | over 2 years ago | $260 -33.32% downside | $254.93 | Benzinga | N/A |
Ryan Zimmerman BTIG | 28.57% 2/7 | over 2 years ago | $268 -31.27% downside | $239.65 | TheFly | Previous targets (6) |
Cowen Cowen Cowen & Co. | 100% 1/1 | over 2 years ago | $283 -27.42% downside | $239.84 | Pulse 2.0 | Previous targets (0) |
Unknown Barclays | N/A | almost 3 years ago | $257 -34.09% downside | $238.76 | Benzinga | N/A |
Matt O'Brien Piper Sandler | 20% 1/5 | almost 3 years ago | $260 -33.32% downside | $206.93 | Pulse 2.0 | Previous targets (4) |
Unknown BTIG | N/A | about 3 years ago | $238 -38.96% downside | $202.61 | Benzinga | N/A |
Unknown BTIG | N/A | about 3 years ago | $244 -37.42% downside | $192.91 | Benzinga | N/A |
Unknown Stifel Nicolaus | N/A | about 3 years ago | $245 -37.16% downside | $193.26 | Benzinga | N/A |
David Toung Argus Research | 33.33% 1/3 | over 3 years ago | $270 -30.75% downside | $232.41 | Pulse 2.0 | Previous targets (2) |
Richard Newitter Truist Financial | 20% 1/5 | over 3 years ago | $280 -28.19% downside | $236.97 | Pulse 2.0 | Previous targets (4) |
Unknown Morgan Stanley | N/A | over 3 years ago | $270 -30.75% downside | $236.97 | Benzinga | N/A |
Matt O'Brien Piper Sandler | 20% 1/5 | over 3 years ago | $290 -25.62% downside | $241.26 | Pulse 2.0 | Previous targets (4) |
Unknown Wells Fargo | N/A | over 3 years ago | $286 -26.65% downside | $246.64 | Benzinga | N/A |
Ryan Zimmerman BTIG | 28.57% 2/7 | over 3 years ago | $278 -28.70% downside | $276.37 | Pulse 2.0 | Previous targets (6) |
Shagun Singh RBC Capital | 100% 1/1 | over 3 years ago | $272 -30.24% downside | $261.7 | Pulse 2.0 | Previous targets (0) |
Lee Hambright Bernstein | 100% 1/1 | over 3 years ago | $295 -24.34% downside | $267.34 | Pulse 2.0 | Previous targets (0) |
Travis Steed Bank of America Securities | 100% 1/1 | over 3 years ago | $300 -23.06% downside | $266.47 | Pulse 2.0 | Previous targets (0) |
Matthew Taylor UBS | 100% 1/1 | over 3 years ago | $267 -31.52% downside | $247.76 | StreetInsider | Previous targets (0) |
Robbie Marcus J.P. Morgan | 100% 1/1 | over 3 years ago | $265 -32.04% downside | $247.76 | TipRanks Contributor | Previous targets (0) |
Danielle Antalffy Leerink Partners | 100% 1/1 | over 3 years ago | $285 -26.91% downside | $247.76 | TipRanks Contributor | Previous targets (0) |
Ryan Zimmerman BTIG | 28.57% 2/7 | over 3 years ago | $273 -29.98% downside | $247.76 | TipRanks Contributor | Previous targets (6) |
Matthew O'Brien Piper Sandler | 100% 1/1 | over 3 years ago | $315 -19.21% downside | $244.7 | TheFly | Previous targets (0) |
Pito Chickering Deutsche Bank | 100% 1/1 | over 3 years ago | $285 -26.91% downside | $254.03 | TipRanks Contributor | Previous targets (0) |
Rick Aristotle Munarriz Motley Fool | 100% 1/1 | almost 4 years ago | $278 -28.70% downside | $259.21 | TheFly | Previous targets (0) |
Jason Wittes Loop Capital Markets | 100% 1/1 | almost 4 years ago | $305 -21.78% downside | $253.11 | TheFly | Previous targets (0) |
David Toung Argus Research | 33.33% 1/3 | about 4 years ago | $320 -17.93% downside | $267.18 | TheFly | Previous targets (2) |
Steven Lichtman Oppenheimer | 100% 1/1 | about 4 years ago | $288 -26.14% downside | $266.68 | TheFly | Previous targets (0) |
Matt Miksic Credit Suisse | 100% 1/1 | about 4 years ago | $311 -20.24% downside | $266.68 | TheFly | Previous targets (0) |
Josh Jennings Cowen & Co. | 100% 1/1 | about 4 years ago | $305 -21.78% downside | $266.68 | StreetInsider | Previous targets (0) |
Kyle Rose Canaccord Genuity | 50% 1/2 | about 4 years ago | $290 -25.62% downside | $266.68 | StreetInsider | Previous targets (1) |
Stryker Financial Estimates
Stryker Revenue Estimates
Stryker EBITDA Estimates
Stryker Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $17.10B N/A | $18.44B 7.83% | $20.49B 11.10% | Avg: $24.01B Low: $23.57B High: $24.34B avg. 17.17% | Avg: $25.81B Low: $25.53B High: $26.07B avg. 7.48% | Avg: $28.30B Low: $27.98B High: $28.58B avg. 9.62% | Avg: $29.84B Low: $29.51B High: $30.14B avg. 5.44% |
Net Income
% change YoY
| $1.99B N/A | $2.35B 18.25% | $3.16B 34.22% | Avg: $4.48B Low: $3.71B High: $4.74B avg. 41.81% | Avg: $5.00B Low: $4.18B High: $5.27B avg. 11.47% | Avg: $6.42B Low: $6.33B High: $6.50B avg. 28.39% | Avg: $6.90B Low: $6.80B High: $6.99B avg. 7.44% |
EBITDA
% change YoY
| $3.78B N/A | $4.24B 12.19% | $4.93B 16.34% | Avg: $5.60B Low: $5.50B High: $5.68B avg. 13.58% | Avg: $6.02B Low: $5.95B High: $6.08B avg. 7.48% | Avg: $6.60B Low: $6.53B High: $6.66B avg. 9.62% | Avg: $6.96B Low: $6.88B High: $7.03B avg. 5.44% |
EPS
% change YoY
| $5.29 N/A | $6.23 17.76% | $8.34 33.86% | Avg: $11.79 Low: $9.68 High: $12.37 avg. 41.40% | Avg: $13.08 Low: $10.9 High: $13.74 avg. 10.87% | Avg: $16.74 Low: $16.5 High: $16.96 avg. 28.05% | Avg: $17.99 Low: $17.73 High: $18.22 avg. 7.44% |
Operating Expenses
% change YoY
| $8.28B N/A | $8.53B 3.07% | $9.20B 7.88% | Avg: $8.67B Low: $8.52B High: $8.79B avg. -5.75% | Avg: $9.32B Low: $9.22B High: $9.42B avg. 7.48% | Avg: $10.22B Low: $10.11B High: $10.32B avg. 9.62% | Avg: $10.78B Low: $10.66B High: $10.89B avg. 5.44% |
FAQ
What is Stryker stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.28% in 2025-2028.
We have gathered data from 16 analysts. Their low estimate is 3.71B, average is 4.48B and high is 4.74B.
What is Stryker stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.93% in 2025-2028.
We have gathered data from 21 analysts. Their low revenue estimate is $23.57B, average is $24.01B and high is $24.34B.
What is Stryker stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 21.94% in 2025-2028.
We have gathered data from 16 analysts. Their low earnings per share estimate is $9.68, average is $11.79 and high is $12.37.
What is the best performing analyst?
In the last twelve months 6 analysts have been covering Stryker stock. The most successful analyst is Richard Newitter whose win rate is 20%. He has correctly predicted 1/5 price targets.